• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

John Maraganore

FDA
Biotech

Biotech CEOs say they already feel impact of FDA restructure

Certain biotechs have already seen effects from the FDA restructure, with industry stakeholders pushing for the rapid restoration of key functions.
Gabrielle Masson Apr 10, 2025 1:56pm
skyscrapers in New York City

City Tx breaks ground with $135M, blueprints from Maraganore

Oct 8, 2024 10:38am
martial arts fighter

Judo throws down $100M to knock out kidney disease

Oct 7, 2024 10:42am
games game controller controller computer

New cell therapy biotech emerges from the lab of George Church

Sep 19, 2024 6:30am
parachute chutes

Bayer undergoes leadership shake-up—Chutes & Ladders

Mar 22, 2024 9:30am
orbital landscape dimensions

Orbital raises $270M for next-gen RNA meds, loops in 2 new execs

Apr 26, 2023 6:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings